α4-integrin receptor occupancy ntz (Biogen Inc)
90
Structured Review
Biogen Inc
α4-integrin receptor occupancy ntz
α4 Integrin Receptor Occupancy Ntz, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B14-integrin+receptor+occupancy+ntz/%CE%B14+integrin+receptor+occupancy+ntz/pm30939392-59-3-27
Average 90 stars, based on 1 article reviews
α4 Integrin Receptor Occupancy Ntz, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B14-integrin+receptor+occupancy+ntz/%CE%B14+integrin+receptor+occupancy+ntz/pm30939392-59-3-27
Average 90 stars, based on 1 article reviews
α4-integrin receptor occupancy ntz - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Evaluation of natalizumab pharmacokinetics and pharmacodynamics with standard and extended interval dosing. Article Snippet: Backgound: Natalizumab (NTZ) is a highly efficacious therapeutic for multiple sclerosis (MS), but treatment is associated with an increased risk of progressive multifocal leukoencephalopathy (PML).. Extended interval dosing (EID) of NTZ has been proposed as an alternative dosing strategy to reduce PML risk.. Pharmacokinetic (PK) and pharmacodynamic (PD) profiles of standard interval dosing (SID) and EID under real-world circumstances remain poorly characterized. |